PCMI
Paradigm Capital Management Inc’s Standard BioTools LAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.9K | Sell |
17,457
-230,943
| -93% | -$277K | ﹤0.01% | 122 |
|
|
2025
Q1 | $268K | Hold |
248,400
| – | – | 0.01% | 121 |
|
|
2024
Q4 | $435K | Sell |
248,400
-301,600
| -55% | -$528K | 0.02% | 113 |
|
|
2024
Q3 | $1.06M | Hold |
550,000
| – | – | 0.05% | 96 |
|
|
2024
Q2 | $974K | Hold |
550,000
| – | – | 0.04% | 98 |
|
|
2024
Q1 | $1.49M | Buy |
550,000
+500,000
| +1,000% | +$1.36M | 0.07% | 87 |
|
|
2023
Q4 | $111K | Buy |
+50,000
| New | +$111K | 0.01% | 130 |
|
|
2022
Q1 | – | Sell |
-771,100
| Closed | -$3.02M | – | 155 |
|
|
2021
Q4 | $3.02M | Sell |
771,100
-144,900
| -16% | -$568K | 0.14% | 92 |
|
|
2021
Q3 | $6.04M | Hold |
916,000
| – | – | 0.31% | 74 |
|
|
2021
Q2 | $5.64M | Sell |
916,000
-329,000
| -26% | -$2.03M | 0.27% | 76 |
|
|
2021
Q1 | $5.63M | Sell |
1,245,000
-281,100
| -18% | -$1.27M | 0.29% | 71 |
|
|
2020
Q4 | $9.16M | Buy |
1,526,100
+542,000
| +55% | +$3.25M | 0.55% | 47 |
|
|
2020
Q3 | $7.31M | Sell |
984,100
-521,600
| -35% | -$3.88M | 0.61% | 52 |
|
|
2020
Q2 | $6.04M | Buy |
1,505,700
+18,000
| +1% | +$72.2K | 0.55% | 50 |
|
|
2020
Q1 | $3.78M | Buy |
1,487,700
+809,800
| +119% | +$2.06M | 0.46% | 56 |
|
|
2019
Q4 | $2.36M | Buy |
677,900
+552,700
| +441% | +$1.92M | 0.18% | 86 |
|
|
2019
Q3 | $580K | Buy |
+125,200
| New | +$580K | 0.05% | 125 |
|